(2,3-Dihydrobenzo[b][1,4]dioxin-5-yl)methanamine hydrochloride, 95.0%, 5g

4-NITRO-1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-PYRAZOLE, 95.0%, 1g

(4-pyridin-2-ylbutyl)amine, 95.0%, 1g

4-Isopropyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde, 95%, 1g

Hybridisation vial Non-coated, Height, 150 mm, 35 mm, 1 Piece

(1S,2S)-2-(4-CHLOROPHENYL)CYCLOPROPANE-1-CARBOXYLIC ACID, 95.0%, 100mg

2-Bromo-3-chloro-5-(trifluoromethyl)pyridine, 97.0%, 5g

(1E)-N',2-dihydroxy-3-methylbutanimidamide, 95.0%, 5g

Bis(tetrabutylammonium) Tetracyanodiphenoquinodimethanide>98.0%(N)100mg

1-Bromo-5-chloropentane, 98.0%, 1kg

Invertase Solution50g

(4-(1-Cyanocyclopropyl)phenyl)boronic acid, 95.0%, 25g

3-Aminopiperidine-2,6-dione, 95.0%, 5g